Victor Mifsud
Head of Real World Evidence at Noetic Fund
Updated
Investment focus
Stages: seed, early-stage
Sectors: biotech, pharmaceuticals, psychedelics, digital health, wellness
Noetic Fund thesis
Noetic invests in early-stage technologies addressing mental health and wellbeing through novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables and evidence-backed solutions targeting root causes with focus on early intervention and prevention.
Is Noetic Fund the right investor for you?
DryPowder ranks 500+ funds by fit with your startup's stage, sector, and thesis.
Find my top investors →Frequently asked questions
What does Victor Mifsud invest in?
Victor Mifsud is Head of Real World Evidence at Noetic Fund. They focus on psychedelics, health optimization. Noetic Fund's thesis: Noetic invests in early-stage technologies addressing mental health and wellbeing through novel drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, wearables and eviden Noetic Fund typically invests at seed, early-stage.
How do I reach Victor Mifsud?
The most effective approach is a warm introduction. Use DryPowder's fund matching to see how well your startup aligns with Noetic Fund's thesis and Victor Mifsud's focus areas (psychedelics, health optimization) — the tool gives you a fit score and specific talking points to use in your outreach.
What other investors are similar to Victor Mifsud?
DryPowder tracks 500+ VC funds and their investment teams. Use the fund matching tool to find other seed, early-stage-stage investors focused on psychedelics, health optimization that fit your startup's profile.